XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.22.4

SELECTED FINANCIAL STATEMENT INFORMATION | 3 Months Ended
--- | ---
Jan. 31, 2023
Selected Financial Statement Information [Abstract] |
Selected Financial Statement Information [Text Block] | SELECTED FINANCIAL STATEMENT INFORMATION Accounts Receivable
(in thousands) |  | January 31, 2023 |  | October 31, 2022
Accounts receivable |  | $335,706 |  |  | $303,181 |
Less: Allowance for doubtful accounts |  | (9,942) |  |  | (8,333) |
Accounts receivable, net |  | $325,764 |  |  | $294,848 |
Inventories
(in thousands) |  | January 31, 2023 |  | October 31, 2022
Finished products |  | $338,764 |  |  | $285,024 |
Work in process |  | 80,861 |  |  | 59,739 |
Materials, parts, assemblies and supplies |  | 277,870 |  |  | 237,708 |
Inventories, net of valuation reserves |  | $697,495 |  |  | $582,471 |
Property, Plant and Equipment
(in thousands) |  | January 31, 2023 |  | October 31, 2022
Land |  | $19,161 |  |  | $17,579 |
Buildings and improvements |  | 168,765 |  |  | 148,598 |
Machinery, equipment and tooling |  | 353,710 |  |  | 322,252 |
Construction in progress |  | 22,040 |  |  | 14,533 |
|  | 563,676 |  |  | 502,962 |
Less: Accumulated depreciation and amortization |  | (289,273) |  |  | (277,083) |
Property, plant and equipment, net |  | $274,403 |  |  | $225,879 |
Accrued Customer Rebates and Credits The aggregate amount of accrued customer rebates and credits included within accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets was $19.3 million as of January 31, 2023 and $17.9 million as of October 31, 2022. The total customer rebates and credits deducted within net sales for the three months ended January 31, 2023 and 2022 was $2.2 million and $1.7 million, respectively. Research and Development Expenses The amount of new product research and development ("R&D") expenses included in cost of sales for the three months ended January 31, 2023 and 2022 is as follows (in thousands):
|  | Three months ended January 31,
|  | 2023 |  | 2022
R&D expenses |  | $20,238 |  |  | $18,396 |
Redeemable Noncontrolling Interests The holders of equity interests in certain of the Company's subsidiaries have rights ("Put Rights") that may be exercised on varying dates causing the Company to purchase their equity interests through fiscal 2032. The Put Rights, all of which relate either to common shares or membership interests in limited liability companies, provide that the cash consideration to be paid for their equity interests (the "Redemption Amount") be at fair value or a formula that management intended to reasonably approximate fair value based solely on a multiple of future earnings over a measurement period. Management's estimate of the aggregate Redemption Amount of all Put Rights that the Company could be required to pay is as follows (in thousands):
|  | January 31, 2023 |  | October 31, 2022
Redeemable at fair value |  | $300,522 |  |  | $300,693 |
Redeemable based on a multiple of future earnings |  | 39,765 |  |  | 26,908 |
Redeemable noncontrolling interests |  | $340,287 |  |  | $327,601 |
As discussed in Note 2, Acquisition, the Company, through HEICO Electronic, acquired 93.69% of the common stock of Exxelia in January 2023. As part of the liquidity agreement, the noncontrolling interest holders have the right to cause the Company to purchase their equity interest beginning in fiscal 2028, or sooner under certain conditions, and the Company has the right to purchase the same equity interest beginning in the same period. As discussed in Note 2, Acquisition, the Company, as a result of its acquisition of Exxelia, acquired 90% of the stock of Alcon in January 2023. As part of the shareholders' agreement, the noncontrolling interest holder has the right to cause the Company to purchase their equity interest beginning in fiscal 2025, or sooner under certain conditions, and the Company has the right to purchase the same equity interest beginning in the same period. During fiscal 2022, the holder of a 19.9% noncontrolling equity interest in a subsidiary of the FSG that was acquired in fiscal 2015 exercised their option to cause the Company to purchase their noncontrolling interest over a four-year period ending in fiscal 2026. Accordingly, the Company acquired one-fourth of such interest in December 2022, which increased the Company's ownership interest in the subsidiary to 85.1%. Accumulated Other Comprehensive Loss Changes in the components of accumulated other comprehensive loss for the three months ended January 31, 2023 are as follows (in thousands):
|  | Foreign Currency Translation |  | Defined Benefit Pension Plan |  | Accumulated Other Comprehensive Loss
Balances as of October 31, 2022 |  | ($45,369) |  |  | ($1,130) |  |  | ($46,499) |
Unrealized gain |  | 27,126 |  |  | — |  |  | 27,126 |
Amortization of unrealized loss |  | — |  |  | 15 |  |  | 15 |
Balances as of January 31, 2023 |  | ($18,243) |  |  | ($1,115) |  |  | ($19,358) |

X
- References No definition available. + Details
Name: | hei_SelectedFinancialStatementInformationAbstract
Namespace Prefix: | hei_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration